Keywords: xolair, being, evaluated, peanut, allergy, firm, tanox

Xolair being evaluated in peanut allergy

Article | 19 July 2004

Print This

US firm Tanox says that the first patient has been enrolled in a PhaseII clinical trial evaluating the safety and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in